- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
The fate of the three major pharmaceutical enterprises run-off battle (Part Two)
PAGE \* MERGEFORMAT 24
The fate of the three major pharmaceutical enterprises run-off battle (Part Two)
OTC single-product Guoyi Way
Fuk Loi broadcaster in the 21st century vice president Wang Hongjun
Count the rapid development of domestic pharmaceutical enterprises, such as Guizhou Yi Bai, amendment medicine, Wuhan Ma Ying Long Pharmaceutical, Guangxi Lingfeng,, we will find that have very similar place, is a product driven by a business to take off. In fact, not only in China, look at the world’s pharmaceutical giants, there is a business which relies on a lot of variety to win it? Is often a species that is billions of dollars in annual sales. China is currently doing the larger pharmaceutical companies, such as stone medicine, Chinese medicine, Eastern medicine and so on, do Wuliushiyi yuan a year in sales, single-items annual Guoyi, over 200 million not much. Most of the SMEs is easily grab hundreds of varieties, there is no primary and secondary, or even market their products to cannibalize each other. I believe that only when the enterprises have Guoyi a single product, will it truly on the stage, the survival will be more calm. Based pharmaceutical companies have a certain order to achieve a single product Guoyi, consider the following methods:
First, pooling of resources to support the first Zhuang a ‘child’
Business people, financial, and material resources are limited, what are doing anything but easy to do well.
Is the enterprise product like a child, which all came to watch liked, but also be able to earn much more money back, so some companies on which product is not willing to cold, to the point of support for this product, that product Point allocated costs, the results of which have no hungry children may also did not eat, but did not long Zhuang. Dwarf-level products with a group of enterprises will not collapse, but will live a difficult, living running around in circles (because the average product-oriented enterprises consuming more
您可能关注的文档
- Status of Traditional Medicine of Ethnic Minorities face construction with Chinese characteristics the national medical system.doc
- State liquor Maotai prices reasonable - 10 to see prices Maotai.doc
- Stellera chameajasme act on human lung cancer cell NCI H446 [H446] the quantitative expression of telomerase.doc
- Stem Cell Research Progress on the treatment of retinal diseases,.doc
- Stem cell therapy of diabetes Recent.doc
- Steel Enterprise Marketing Financial Crisis.doc
- Status of preparation of traditional Chinese medicine treatment of vitiligo_0.doc
- Start miscalculation round loser - Japan's defeat in the Chinese market OS Group Comments.doc
- Steroid hormone GC MS analysis of keto derivatives of Research Progress.doc
- Status of the nature of TCM and the introduction of new trends in systems biology.doc
最近下载
- 2024年秋学期部编版初中语文八年级上册教学计划及其教学进度表.docx VIP
- 统编教材语文五年级上册第四单元单元整体解读.pptx VIP
- GSK990MA数控系统编程及操作手册.pdf VIP
- 2025鄂尔多斯市城市建设投资集团招聘92人笔试模拟试题及答案解析.docx VIP
- 2024年人教版小学四年级上册音乐教案全册.docx VIP
- 人工智能对人类发展利大于弊VS弊大于利辩论赛 正方辩词一辩、二辩、三辩、四辩发言稿.docx VIP
- 西安电子科技大学电子信息与通信工程类专业培养方案(本科层次).pdf VIP
- 人类发展核电利大于弊VS弊大于利辩论赛 反方辩词一辩、二辩、三辩、四辩发言稿.docx VIP
- (2024秋新版)人教PEP版三年级英语上册全册教案.doc
- ISO15189质量手册--输血科通用模版(文档-100页).docx VIP
文档评论(0)